Which ETFs own TRIL?
Trillium Therapeutics Inc. — 1 ETFs hold it, worth $882.9K across 160.99K shares.
Holdings as of Apr 17, 2023 — portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | CNCR Loncar Cancer Immunotherapy ETF | 3.29% | 160.99K | $882.9K | $12.7M | Biotech | +1.58% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.